Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: A psychological component is the rule

American Journal of Gastroenterology

Volumn 104, Issue 7, 2009, Pages 1772-1779

  Choung, Rok Seon ^a   Locke, G Richard ^a   Zinsmeister, Alan R ^b   Schleck, Cathy D ^b   Talley, Nicholas J ^a,c  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DISTRESS SYNDROME; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABLE COLON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOSOCIAL DISORDER; QUESTIONNAIRE; SCORING SYSTEM; SOMATIC SYMPTOM CHECKLIST; SOMATIZATION; SYMPTOM; SYMPTOM CHECKLIST 90; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; IRRITABLE BOWEL SYNDROME; LIFE CHANGE EVENTS; MALE; MIDDLE AGED; PROBABILITY; PSYCHIATRIC STATUS RATING SCALES; PSYCHOLOGY; QUESTIONNAIRES; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SICKNESS IMPACT PROFILE; SOMATOFORM DISORDERS; STRESS, PSYCHOLOGICAL;

EID: 67650423948     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.239     Document Type: Article

References (54)

1. Longstreth GF. Defnition and classification of irritable bowel syndrome: current consensus and controversies. Gastroenterol Clin North Am 2005;34:173-87.
2. Thompson WG. Irritable bowel syndrome: pathogenesis and management. Lancet 1993; 341: 1569-72.
3. Zighelboim J, Talley NJ. What are functional bowel disorders? Gastroenter-ology 1993; 104: 1196-20.
4. Levy RL, Olden KW, Nalibof BD et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 2006; 130: 1447-58.
5. Mayer EA, Nalibof BD, Chang L et al. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2001; 280: G519-24.
6. Monnikes H, Tebbe JJ, Hildebrandt M et al. Role of stress in functional gastrointestinal disorders. Evidence for stress-induced alterations in gastrointestinal motility and sensitivity. Dig Dis 2001; 19: 201-11.
7. Talley NJ, Fett SL, Zinsmeister AR. Self-reported abuse and gastrointestinal disease in outpatients: association with irritable bowel-type symptoms. Am J Gastroenterol 1995; 90: 366-71.
8. Delvaux M, Denis P, Allemand H. Sexual abuse is more frequently reported by IBS patients than by patients with organic digestive diseases or controls. Results of a multicentre inquiry. French Club of Digestive Motility Eur J Gastroenterol Hepatol 1997;9:345-52.
9. Ali A, Toner BB, Stuckless N et al. Emotional abuse, self-blame, and self-silencing in women with irritable bowel syndrome. Psychosom Med 2000;62:76-82.
10. Whitehead WE, Crowell MD, Robinson JC et al. Efects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut 1992; 33: 825-30.
11. Bennett EJ, Tennant CC, Piesse C et al. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut 1998; 43: 256-6.
12. Drossman DA, McKee DC, Sandler RS et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988; 95: 701-8.
13. Whitehead WE, BosmajianL, Zonderman AB, et al., Schuster MM Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology 1988;95:709-14.
14. Whitehead WE, Crowell MD. Psychologic considerations in the irritable bowel syndrome. Gastroenterol Clin North Am 1991;20:249-67.
15. Smith RC, Greenbaum DS, Vancouver JB et al. Psychosocial factors are associated with health care seeking rather than diagnosis in irritable bowel syndrome. Gastroenterology 990;98:293-301.
16. Drossman DA, Camilleri M, Mayer EA et al. AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123: 2108-31.
17. Locke GR III, Weaver AL, Melton LJ III et al. Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol 2004; 99: 350-7.
18. Talley NJ, Boyce PM, Jones M. Predictors of health care seeking for irritable bowel syndrome: a population based study. Gut 1997; 41: 394-8.
19. Koloski NA, Boyce PM, Talley NJ. Somatization an independent psychosocial risk factor for irritable bowel syndrome but not dyspepsia: a population-based study. Eur J Gastroenterol Hepatol 2006; 18: 1101-9.
20. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002; 122: 1140-56.
21. Whorwell PJ, McCallum M, Creed FH et al. Non-colonic features of irritable bowel syndrome. Gut 1986; 27: 37-40.
22. Maxton DG, Morris J, Whorwell PJ. More accurate diagnosis of irritable bowel syndrome by the use of ' non-colonic ' symptomatology. Gut 1991;32:784-6.
23. Choung RS, Locke GR III, Zinsmeister AR et al. Alternating bowel pattern: what do people mean? Aliment Pharmacol Ther 2006; 23: 1749-55.
24. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc 996;71:266-74.
25. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am 1981;245:54-63.
26. Talley NJ, Zinsmeister AR, Schleck CD et al. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992; 102: 1259-68.
27. Talley NJ, Zinsmeister AR, Van Dyke C et al. Epidemiology of co-lonic symptoms and the irritable bowel syndrome. Gastroenterology 1991;101:927-34.
28. Talley NJ, Phillips SF, Melton J III et al. A patient questionnaire to identify bowel disease. Ann Intern Med 1989;111:67-4.
29. Talley NJ, O'Keefe EA, Zinsmeister AR et al. Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology 1992;102:895-901.
30. Talley NJ, Weaver AL, Zinsmeister AR et al. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992; 136: 165-77.
31. Talley NJ, Phillips SF, Wiltgen CM et al. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc 1990; 65: 1456-79.
32. Attanasio V Andrasik F, Blanchard EB et al. Psychometric properties of the SUNYA revision of the psychosomatic symptom checklist. J Behav Med 1984;7:247-57.
33. Locke GR III, Zinsmeister AR, Talley NJ et al. Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol 2000;95:57-65.
34. Derogatis LR, Rickels K, Rock AF. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry 1976; 128: 280-9.
35. Castillo EJ, Camilleri M, Locke GR et al. A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia. Clin Gastroenterol Hepatol 2004;2:985-96.
36. Evans JM, Fleming KC, Talley NJ et al. Relation of colonic transit to functional bowel disease in older people: a population-based study. J Am Geriatr Soc 1998;46:83-7.
37. Talley NJ, Fleming KC, Evans JM et al. Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol 1996;91:19-25.
38. Saito YA, Talley NJ, L JM et al. The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates. Neurogas-troenterol Motil 2003;15:687-94.
39. Talley NJ, Zinsmeister AR, Melton LJ III. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 1995; 142: 76-83.
40. Whitehead WE, Palsson OS, Levy RR et al. Comorbidity in irritable bowel syndrome. Am J Gastroenterol 2007; 102: 2767-76.
41. Sandler RS, Drossman DA, Nathan HP et al. Symptom complaints and health care seeking behavior in subjects with bowel dysfunction. Gastroenterology 984;87:34-8.
42. Koloski NA, Boyce PM, Talley NJ. Is health care seeking for irritable bowel syndrome and functional dyspepsia a socially learned response to illness? Dig Dis Sci 2005; 50: 153-62.
43. Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol 2002; 97: 2290-9.
44. Talley NJ, Boyce PM, Jones M. Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study. Gut 1998;42:47-53.
45. Herschbach P, Henrich G, von Rad M. Psychological factors in functional gastrointestinal disorders: characteristics of the disorder or of the illness behavior? Psychosom Med 999;61:148-53.
46. Sayu k GS, Elwing JE, L ustman PJ et al. High somatic symptom burdens and functional gastrointestinal disorders. Clin Gastroenterol Hepatol 2007;5:556-62.
47. Sewitch MJ, Abrahamowicz M, Bitton A et al. Psychological distress, social support, and disease activity in patients with inflammatory bowel disease. Am J Gastroenterol 2001; 96: 1470-9.
48. Mikocka-Walus AA, Turnbull DA, Moulding NT et al. Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review. Inflamm Bowel Dis 2007; 13: 225-34.
49. Fink P, Tof T, Hansen MS et al. Symptoms and syndromes of bodily distress: an exploratory study of 978 internal medical, neurological, and primary care patients. Psychosom Med 2007;69:30-9.
50. Kroenke K. Physical symptom disorder: a simpler diagnostic category for somatization-spectrum conditions. J Psychosom Res 2006; 60: 335-9.
51. Fink P, Rosendal M. Recent developments in the understanding and management of functional somatic symptoms in primary care. Curr Opin Psychiatry 2008;21:182-8.
52. Longstreth GF, Hawkey CJ, Mayer EA et al. Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials. Aliment Pharmacol Ther 2001;15:959-64.
53. Barbara G, Stanghellini V Cremon C et al. Almost all irritable bowel syndromes are post-infectious and respond to probiotics: controversial issues. Dig Dis 2007; 25: 245-8.
54. Melton LJ III. The threat to medical-records research. N Engl J Med 1997; 337: 1466-70.